Mycobacteria, due to their diverse and complex cell wall structures, play a significant role in 2 modulating immune responses (Rook, et al. 2004; Stanford, et al. 2009 ) For several years, 3
Bacillus Calmette-Guerin (BCG), a live attenuated derivative of the slow-growing species 4
Mycobacterium bovis (M. bovis), has been used as a prophylactic vaccine against tuberculosis 5 (TB); though, with variable efficacy (Romano and Huygen 2012) . Moreover, BCG has proven to 6 be successful in the treatment of early non-invasive bladder cancer (Kawai, et al. 2013 ). The 7 investigation of inactivated rapid-growing mycobacteria to be employed as immunomodulators 8 has led to the selection of M. vaccae which was later evaluated as an immunomodulating 9 therapeutic agent in various diseases including TB (Dlugovitzky, et al. 2006; Johnson, et al. 10 2000; Yang, et al. 2011) , leprosy (Abbot, et al. 2002; Truoc, et al. 2001) , psoriasis (Lehrer, et 11 al. 1998) , dermatitis (Arkwright and David 2001) , asthma (Camporota, et al. 2003 ) and a range 12 of cancers (Cananzi, et al. 2013; Eaton, et al. 2002; O'Brien, et al. 2004; Patel, et al. 2008; 13 Stanford, et al. 2008) . M. vaccae was also found to be an effective vaccine that could confer a 14 significant level of protection against TB among HIV-infected individuals who had received BCG 15 vaccination during childhood (von Reyn, et al. 2010) . In all these studies, M. vaccae was used in 16 the form of a heat-killed (HK) preparation that retained its antigenic properties. In spite of the 17 growing interest in the therapeutic implications of HK mycobacterial preparations, the nature of 18 the host immune receptors regulated by these mycobacterial preparations has not been fully 19 defined. Moreover, the exact mechanism by which HK mycobacterial preparations exert their 20 immunomodulatory effects in humans is not fully understood. Nevertheless, in experimental 21 models, immunization with HK M. vaccae was reported to generate CD8 + T cells against M. 22 tuberculosis-infected macrophages (Skinner, et al. 1997) and to downregulate T helper type 2 23 (Th2) responses in murine models of allergic pulmonary inflammation via the induction of 24 regulatory T cells (Zuany-Amorim, et al. 2002) and the priming of dendritic cells (DCs) 25 consistent with a regulatory profile (Adams, et al. 2004) . In vitro studies with human monocyte 26 derived DCs have confirmed the ability of M. vaccae to dampen Th2 responses, via a 27 mechanism dependent on DCs (Le Bert, et al. 2011) . Furthermore, M. vaccae and M. obuense 28 have been shown to promote the anti-tumor activity of human γδT-cells via cytokine release 29 from type-1 myeloid DCs (Fowler, et al. 2012) . M. obuense has gained attention over the past 30 few years as a potential immunotherapeutic agent against cancer and, in a phase 1 study in 31 melanoma patients, it was shown to be safe and well tolerated (Stebbing, et al. 2012) . More 32 recently, in a phase 2 study, the use of M. obuense (NCTC13365) as adjunctive immunotherapy 33 for advanced pancreatic cancer resulted in clinically meaningful increases in overall survival as 1 well as in progression-free survival of patients (Dalgleish, A.G. and The IMAGE I Trial 2 Investigators 2015). Currently, M. obuense (NCTC13365) is being investigated in a phase 2 3 study involving patients with melanoma (NCT01559818). The interactions between different 4 immune cells and between immune cells and soluble factors are mediated by a number of cell 5 surface receptors involved in cellular adhesion, antigen presentation and co-stimulation, 6
cytokine-mediated signaling, and cellular activation (Barclay, et al. 1997) . Therefore, variations 7 in the expression of these receptors would affect the immune cell function thus leading to the 8 modulation of immune responses. Immune responses from healthy volunteers, assessed by the 9 profile of released cytokines, have been extensively analyzed using short-term incubation of 10 human whole blood with a large spectrum of microbial immunostimulants, immunomodulators, 11 or specific antigens (Darcissac, et al. 1996a; Darcissac, et al. 1996b; Duffy, et al. 2014; Kassa, 12 et al. 2012; Reichenbach, et al. 2006) . The immunomodulatory properties of HK M. vaccae or 13 M. obuense in the human whole blood model have not been previously evaluated. In this study, 14 both HK mycobacterial preparations were assessed for their ability to modulate in vitro the 15 expression of immunologically relevant leukocyte surface receptors and to alter cytokine and 16 chemokine secretion in human whole blood. We have also addressed the role of toll-like 17 receptors (TLRs) in mediating the immunomodulatory effects of M. obuense, and evaluated the 18 ability of M. vaccae and M. obuense to induce lymphoproliferative responses in human 19 peripheral blood mononuclear cells (PBMCs) from healthy volunteers. 20
Materials and Methods 21

Antibodies 22
Mouse monoclonal anti-human antibodies purchased from BD Biosciences (San Jose, 23 CA, USA) included: FITC-conjugated CD2 (clone RPA-2.10), CD11a (clone HI111), CD35 24 (clone E11), CD40 (clone 5C3), CD44 (clone L178), CD45 (clone 2D1), CD50 (clone TU41), 25 CD64 (clone 10.1), CD80 (clone L307.4), CD95 (clone DX2), CD195 (clone 2D7/CCR5), HLA-26 DP,DQ,DR (clone Tu39); PEconjugated CD11b (clone ICRF44), (clone WM59), CD36 (clone 27 CB38), CD58 (clone 1C3), CD89 (clone A59), CD102 (clone CBR-1C2/2), CD114 (clone 28 LMM741), CD116 (clone hGMCSFR-M1), CD119 (clone GIR-208), CD122 (clone TU27), 29 CD127 (clone HIL-7R-M21), CD132 (clone AG184), CD137L (clone C65-485), CD206 (clone 30 19.2), PerCP-conjugated CD14 (clone M5E2), HLA-DR (clone G46-6); PE-Cy7-conjugated 31 CD16 (clone 3G8); APC-conjugated CD5 (clone UCHT2), CD11c (clone B-ly6), CD18 (clone 32 6.7), CD21 (clone B-ly4), CD25 (clone M-A251), CD32 (clone FLI8.26), CD54 (clone HA58), 33 CD62L (clone DREG-56), CD86 (clone 2331), CD184 (clone 12G5), HLA-A,B,C (clone G46-1 2.6); Alexa Fluor 647-conjugated CD197 (clone 3D12) and isotype control antibodies: FITC-2 conjugated mouse IgG1 (clone MOPC-21), IgG2a (clone G155-178), IgG2b (clone MPC-11); 3 PE-conjugated mouse IgG1 (clone MOPC-21), IgG2a (clone G155-178), IgM (clone G155-228); 4 PerCPconjugated mouse IgG2a (clone X39); PE-Cy7-conjugated mouse IgG1 (clone MOPC-5 21); APC-conjugated mouse IgG1 (clone MOPC-21), IgG2a (clone G155-178), IgG2b (clone 6 27-35); Alexa Fluor 647 rat IgG2a (clone R35-95). PE-conjugated mouse monoclonal antibodies 7 against human CD282 (clone TL2.1) and CD284 (clone HTA125) and isotype control antibody 8 PE-conjugated mouse IgG2a (clone eBM2a) were obtained from eBioscience (San Diego, CA, 9 USA). Anti-human monoclonal blocking antibodies against TLR-1 (clone H2G2), TLR-2 (clone 10 B4H2), TLR-4 (clone W7C11), TLR-5 (clone Q2G4), TLR-6 (clone C5C8) and isotype control 11 human IgA2 (clone T9C6) and mouse IgG1 (clone T8E5) were purchased from Invivogen 12 (Toulouse, France). 13
HK mycobacterial preparations 14
Sterile vials of HK M. vaccae (NCTC11659, rough strains) and M. obuense 15 (NCTC13365, rough strains) preparations were manufactured, respectively, by Eden Biodesign 16 (Liverpool, UK) and Bio Elpida (Lyon, France), whereby each 1 mg wet-weight of bacilli is 17 equivalent to 10 9 HK organisms. Briefly, both preparations were suspended in borate-buffered 18 saline (BBS; pH 8.0) at 50 mg/ml and autoclaved for 15 min at 121 °C. 19
Blood collection 20
Human peripheral blood was obtained by venipuncture from 36 Caucasian healthy 21 volunteers and was collected into K2 ethylene diamine tetraacetic acid (K2-EDTA) vacutainer 22 tubes (BD Biosciences). The study population had a mean age of 28 ± 8.5 years and included 23 14 females and 22 males. A written informed consent was obtained from each donor and the 24 study protocol was approved by the Faculty Research Ethics Committees at Kingston University 25 and University of Balamand. 26
Stimulation of whole blood cultures 27
Preliminary experiments using 3 and 6 h time points to stimulate whole blood with 28 different concentrations (30, 100 or 300 μg/ml) of HK M. vaccae or M. obuense preparations 29 have revealed that the optimal regulation of surface receptors expression by either 30 mycobacterial preparation was observable at 300 μg/ml (Supplementary Figure 1A) and after 3 31 h of stimulation (Supplementary Figure 1B) . Therefore, these optimized stimulation conditions 32 were employed in all investigations on the expression of surface receptors in which whole blood 1 cultures (total culture volume = 3 ml) were either left unstimulated or were stimulated at 37 °C 2 in a 5% CO2 humidified atmosphere. A similar protocol was adopted for the analysis of 3 cytokines and chemokines levels, except that the stimulation period was extended to 24 h. 4
Whole blood incubated with equivalent amounts of BBS (vehicle) served as unstimulated 5 control. 6
Immunophenotyping of leukocytes 7
After 3 h stimulation, blood leukocyte populations were immunophenotyped for a set of 8 cell surface receptors. A volume of 100 μl of whole blood was incubated for 30 min at room 9 temperature (RT) in the dark with optimized concentrations of the previously mentioned 10 antibodies or isotype control antibodies. Erythrocytes were then lysed by incubation with FACS 11 lysing solution (BD Biosciences) for 10-15 min at RT in the dark. Leukocytes were collected by 12 centrifugation at 350 x g, for 5 min at RT and washed once with Cell Wash solution (BD 13 Biosciences), then re-collected by centrifugation at 350 x g, for 5 min at RT, and finally 14 resuspended in Cell Fix solution (BD Biosciences). Fixed samples were run on a FACSCalibur 15 flow cytometer (BD Biosciences) equipped with an argon ion laser (488nm) and a red diode 16 laser (635nm) and the obtained data was analyzed by means of CellQuestPro software (BD 17 Biosciences). A minimum of 20,000 cells were acquired per sample. The signals were obtained 18 in a linear mode for forward scatter (FSC) and side scatter (SSC) channels and in a logarithmic 19 mode for fluorescence channels. The intensity and color compensation were set by using 20
Calibrite beads (BD Biosciences) in combination with FACSComp software (BD Biosciences), 21
and by running single-color stained blood cells. Lymphocytes and neutrophils were identified by 22 their FSC and SSC properties. Monocytes were identified by their CD14 + / SSC profile, whereas 23 in TLR blocking experiments, monocytes were gated according to their FSC and SSC profile. 24
Bivariate dot plots were generated to determine the percentage of cells positive for the particular 25 surface receptor within a gated cell population. Histogram plots were used to indicate the 26 density of cell surface receptors which were expressed as geometric mean fluorescence 27 intensity (MFI) on receptor-positive cell population. 28
Lymphocyte proliferation assay 29
Peripheral blood was diluted with an equal volume of RPMI 1640 medium (Lonza, 30 Slough, UK) supplemented with standard concentrations of L-glutamine (Lonza), penicillin and 31 streptomycin (Lonza). Blood was then layered over Ficoll-Paque plus (GE Healthcare, Little 32 Chalfont, UK) and centrifuged at 400 x g for 35 min at 19 °C. Peripheral blood mononuclear 1 cells (PBMCs) were then collected from the interface and were washed twice. Finally, PBMCs 2 were resuspended in RPMI medium supplemented with 10% heat-inactivated pooled human AB 3 serum (Lonza). PBMCs were checked for viability (>95%), using the trypan blue exclusion 4 method, were seeded, in triplicates, in 96-well flat-bottom plates (Corning, Tewksbury, USA) at 5 a density of 2x10 5 cells/well, and were stimulated in the presence or absence of increasing 6 concentrations of HK M. vaccae or M. obuense (1, 3, 10, 30, 100 and 300 μg/ml) or 10 μg/ml of 7
Candida albicans (C. albicans) soluble antigen (Greer Laboratories, Lenoir, NC, USA). Cultures 8 were maintained for a period of 7 days at 37 °C in a 5% CO2 humidified incubator. On day 6, 9 PBMC cultures were pulsed with 1μCi/well tritiated thymidine (Perkin Elmer, San Jose, CA, 10 USA) for 16 h. Cells were then harvested onto glass fiber filter disks (Connectorate AG, 11 Dietikon, Switzerland) using a cell harvester (Inotech Biotechnologies, Basel, Switzerland) and 12 radioactivity was measured in a liquid scintillation counter (Perkin Elmer). Unstimulated cultures 13 lacking the antigen and containing equivalent amounts of BBS (vehicle) served as negative 14 controls. The radioactivity of incorporated thymidine was obtained as counts per minute (cpm). 15
Results are presented as stimulation index (SI), which is defined as follows: mean cpm of 16 antigen-stimulated cultures divided by the mean cpm of unstimulated cultures. A donor is 17 considered as a responder to a given antigen if the SI is ≥ 3. 18
Determination of cytokines, chemokines and sCD62L levels 19
The release of soluble mediators, chemokine C-X-C motif ligand 8 (CXCL8)/ IL-8, IFN-α, 20 IFN-γ, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, IL-23 (p19/p40), macrophage inflammatory 21 protein 1 (MIP1)-α, regulated on activation normal T cell expressed and secreted (RANTES), 22 soluble (s) CD62L and TNF-α, was measured in supernatants from whole blood cultures using 23 ELISA (R&D Systems, Abingdon, UK) in accordance with the manufacturer's instructions. 24
Samples were tested in duplicates and the optical densities were read using Multiskan Ascent 25 micro plate reader (Thermo, Waltham, MA, USA). In a restricted set of experiments, sCD62L 26 levels were also assayed in supernatants of purified PBMCs that were cultured in RPMI medium 27 supplemented with 10% heat-inactivated fetal bovine serum (FBS; Lonza) and were left either 28 unstimulated or stimulated with 300 μg/ml of HK M. vaccae or M. obuense for 3 and 6 h. 29
TLR blocking 30
Whole blood was incubated with 10g/ml of cell culture grade, azide-free blocking 31 monoclonal antibodies against TLR1, TLR2, TLR4, TLR5, TLR6 or isotype control antibodies 32 (listed above) for 1 h prior to stimulating whole blood with HK M. obuesne for 3 h. As control 1 experiments for testing the efficiency of TLR blocking, specific TLR ligands (Invivogen) were 2 used. TLR agonists consisted of: Pam3CSk4 (300 ng/ml), HK Listeria monocytogenes (10 8 3 cells/ml), lipopolysaccharide (LPS; purified from Escherichia coli K12; 100 ng/ml), flagellin 4 (purified from Bacillus subtilis; 10 µg/ml) and FSL-1 (100 ng/ml) which signal through TLR2/1, 5 TLR2, TLR4, TLR5 and TLR2/6 respectively. 6
Statistical analysis 7
All statistical analyses were conducted by means of GraphPad Prism software (version 8 6; GraphPad Software, San Diego, CA, USA) by applying paired t-test, Wilcoxon signed rank 9 test or Friedman test followed by Dunn's multiple comparison post hoc test. Data are expressed 10
as mean values ± standard error of the mean (SEM) and differences were considered to be 11 statistically significant at p values < 0.05. 12
Results
13
M. vaccae and M. obuense modulate, in vitro, the expression of surface receptors on 14 monocytes and neutrophils in whole blood 15
The expression levels of a panel of surface receptors on monocytes (Fig. 1 (Fig. 1B) , CD11a, CD44, CD54 and 27 CD58 was significantly upregulated (p < 0.05) on monocytes post stimulation with either 28 mycobacterial preparation (Table 1) . On the other hand, both mycobacteria affected the 29 expression of a restricted number of adhesion receptors on neutrophils. While the expression of 30 CD62L was significantly reduced, a significant increase (p < 0.05) in the expression of only 31 CD18 and CD54 could be detected (Table 2) . 32
Significant variations in the expression of antigen presentation and co-stimulatory 1 receptors on monocytes and neutrophils subsequent to stimulation with mycobacterial 2 preparations were also detected. In unstimulated blood cultures, monocytes lacked the 3 expression of CD80, but stimulation with either mycobacterial preparation induced monocytes to 4 express CD80 (Table 1) . A significant upregulation (p < 0.05) in the expression of CD86 5 (Fig.1A) , HLA-DPDQDR (Fig. 1B) and CD45 was observed on monocytes (Table 1) . We have 6 also noted, using a smaller sample size (n = 9), a significant increase (p < 0.05) in the 7 percentage of CD137L + monocytes following stimulation with M. vaccae or M. obuense from 8 10±1.5 % to 38±5 % and 51±4.1 %, respectively. Stimulation with either mycobacterial 9 preparation caused an increase in the MFI of CD45 on neutrophils; however, this increase was 10 only statistically significant (p < 0.05) with M. vaccae. On the contrary, stimulation with M. 11
vaccae, but not with M. obuense, significantly decreased (p < 0.05) the MFI of HLA-ABC on 12 neutrophils ( Table 2 ). Members of the pattern recognition receptors (PRRs), CD14, CD36, and 13 CD206, displayed an upregulated expression (p < 0.05) on monocytes after stimulation with 14 either mycobacterial preparation (Table 1 (Table 1) . On the other hand, both mycobacterial 24 preparations induced a modest but significant enhancement (p < 0.05) in the expression of 25 CD64 and CD89 on monocytes (Table 1) . On neutrophils, a significant elevation (p < 0.05) in 26 the expression of CD11c, CD16, CD35 and CD64 was observed following stimulation with either 27 mycobacterial preparation, whereas a significant elevation (p < 0.05) in the expression of 28 CD11b and CD89 was only noted following stimulation with M. vaccae (Table 2) . 29
Significant variations in the expression of cytokine and chemokine receptors, on 30 monocytes and neutrophils, were detected following stimulation with either of the HK 31 mycobacteria. Both preparations were equipotent at significantly upregulating (p < 0.05), on 32 monocytes, the expression of CD116, CD127 and CD132, as well as at significantly 33 downregulating (p < 0.05) the expression of CD184 (Fig. 1A ) and CD119 (Table 1) In 1 neutrophils, stimulation with either M. vaccae or M. obuense significantly reduced (p < 0.05) the 2 percentage of cells expressing CD184 and significantly downregulated (p < 0.05) the MFI of 3 CD119 (Table 2) . In addition, when tested on a smaller sample of 9 donors, the MFI of CD114 4 was found to be downregulated following mycobacterial stimulation (unstimulated: 97±4; M. 5 vaccae: 41±1; M. obuense: 55±4). However, this effect only attained statistical significance (p < 6 0.05) with M. vaccae. In this short-term in vitro assay, neither M. vaccae nor M. obuense 7 induced statistically significant variations in the expression level of any of the screened surface 8 receptors on lymphocytes (data not shown). 9 TLR-1 and TLR-2 contribute to the M. obuense-induced upregulation of CD11c and HLA-10
DR expression on monocytes 11
TLR-2 has been previously shown to play a role in mediating the main transcriptional 12 responses occurring after DC stimulation with HK M. vaccae (Le Bert, et al. 2011) . In order to 13 examine whether TLR-2 and other TLRs (TLR-1, 4, 5 and 6) are involved in mediating the M. 14 obuense-induced upregulation of surface receptors on monocytes in whole blood, TLR blocking 15 experiments (n = 6) with specific antibodies against TLR-1, TLR-2, TLR-4, TLR-5 and TLR-6 16 were performed on the expression of one adhesion receptor (CD11c) and another receptor 17 involved in antigen presentation (HLA-DR), both of which displayed significant variations on 18 monocytes upon mycobacterial stimulation. The blocking capacity of these antibodies was 19 initially confirmed in control experiments using stimulation with specific TLR ligands, as 20 described in materials and methods ( Fig. 2A) . 21
Blocking either TLR-1 or TLR-2 significantly abrogated (p < 0.05) the M. obuense-induced 22 upregulation of the two tested receptors (Fig. 2B) . Analysis of combined blocking with anti-TLR1 23 and anti-TLR2, versus the blocking induced by either antibody separately, resulted in an 24 improved blocking effect which reached statistical significance (p < 0.05) versus either antibody 25 in the case of CD11c, but only against anti-TLR2 in the case of HLA-DR. However, 26 simultaneous blocking of TLR-2 and TLR-6 was comparable to the effect observed with blocking 27 TLR-2 alone in reversing the M. obuense-induced expression of CD11c and HLA-DR (Fig. 2B) . 28
Blocking of TLR-4, 5 and 6 did not cause any significant reduction in the M. obuense-induced 29 upregulation of CD11c and HLA-DR ( of 24 h. Among the 12 screened cytokines, IL-6 and TNF-α levels were markedly increased (p < 5 0.05) in response to stimulation with M. vaccae or M. obuense, whereas IL-10 levels were 6 significantly elevated (p < 0.05) only after stimulation with M. vaccae (Fig. 3) . The secreted 7 levels of the 3 studied chemokines also showed a significant increase following mycobacterial 8 stimulation. A 45-and 42-fold increase (p < 0.05) in CXCL8/IL-8 levels was detected after 9 stimulation with M. vaccae and M. obuense, respectively (Fig. 3) . Moreover, blood stimulation 10 with M. vaccae or M. obuense significantly induced (p < 0.05) MIP-1α production (Fig. 3) . 11
Likewise, RANTES levels were increased in response to stimulation with M. vaccae or M. 12 obuense; however, this increase attained statistical significance (p < 0.05) only for the latter 13 (Fig. 3) . No significant difference in IL-18 levels was observed between unstimulated (612±71 14 pg/ml) and M. vaccae-(638±65 pg/ml) or M. obuense-(641±70 pg/ml) stimulated blood cultures. 15
Moreover, IFN-α, IFN-γ, IL-2, IL-4, IL-5, IL-12 (p70), IL-13 and IL-23 (p19/p40) levels in 16 unstimulated and mycobacteria-stimulated blood cultures were below the detection limit of the 17 employed assays. 18
In order to determine whether the observed M. vaccae-and M. obuense-induced decrease in 19 CD62L surface expression was associated with an increase in the release of sCD62L, 20 supernatants from unstimulated and mycobacteria-stimulated whole blood cultures were 21 collected. There was no significant difference (p > 0.05) in sCD62L levels in culture 22 supernatants after 3, 6 or 24 h of mycobacterial stimulation when compared with their respective 23 unstimulated controls (Supplementary Figure 2) . Moreover, using purified PBMC cultures from 6 24 different donors, we could not detect sCD62L levels in the supernatants of unstimulated or 25 mycobacteria-stimulated PBMCs tested after 3 and 6 h culture periods. 26
M. vaccae and M. obuense induce proliferative responses of PBMCs 27
In order to determine the optimal concentrations of HK M. vaccae and M. obuense that 28 are capable of inducing strong proliferative responses in PBMCs from healthy donors, different 29 concentrations (1, 3, 10, 30, 100 and 300 μg/ml) of either mycobacterial preparation were tested 30 on 4 separate donors (Fig. 4A) . At the lowest and highest concentrations, only weak or no 31 responses could be detected to either preparation (Fig. 4A) . To further verify our data, PBMCs 32 from 8 additional donors were tested at concentrations ranging from 3-100 μg/ml. Results of 33 proliferative responses from the 12 different donors tested revealed that the highest proliferative 1 responses to M. obuense were induced at 3 μg/ml (Fig. 4B ), which attained a statistically 2 significant difference (p < 0.05) versus 30 or 100 μg/ml. In contrast, maximal responses to M. 3 vaccae, noted at 10 μg/ml, were nearly equivalent to those induced by 30 μg/ml and were 4 significantly higher (p < 0.05) than those induced by 100 μg/ml. At the 3 μg/ml concentration, the 5 M. obuense-induced proliferative responses were significantly higher (p < 0.05) than the 6 responses induced by M. vaccae, whereas the reverse was true at the 30 μg/ml concentration 7 (Fig. 4B) . Soluble recall antigen of C. albicans (10 µg/ml) was included in the proliferation 8 assays as a positive control on account of its known potency to induce strong PBMC 9 proliferative responses. PBMCs from all tested donors showed high proliferative responses to C. 10 albicans (Mean SI = 134±39) and these responses were significantly higher (p < 0.05) than 11 those induced by M. vaccae or M. obuense. 12
Discussion
13
Identifying the outcome of interaction of HK mycobacteria with immune cells is a crucial 14 step in the process of assessing their immunomodulatory properties for potential 15 immunotherapeutic applications. Our study is the first to utilize the established human whole 16 blood model (Darcissac, et al. 1996a) with either mycobacterial preparation upregulated the expression of the adhesion receptors, 25 CD2, CD11a, CD44 and CD58 on monocytes and of CD18 and CD54 on monocytes and 26 neutrophils. These findings are similar to those previously reported following whole blood 27 stimulation with the mycobacterial cell wall component muramyl dipeptide (MDP) or with 28 endotoxin (Darcissac, et al. 1996a ). The increased expression of CD2, and more importantly of 29 its ligand CD58 on monocytes, may indicate an increased ability of monocyte-macrophage cells 30 to adhere to T lymphocytes which constitutively express the CD2 receptor (Lopez, et al. 2001) . 31 Accordingly, the immunomodulating activity of mycobacterial preparations may depend on their 32 ability to regulate CD58 expression on antigen presenting cells (APCs), thereby enhancing 33 antigen presentation and induction of adaptive immunity (Wingren, et al. 1995) . Similarly, 1 increased expression of CD54 on APCs may contribute to antigen-specific T cell activation by 2 enhancing the adhesion of T cells to APCs (Gaglia, et al. 2000) . The most intriguing observation 3 was the dramatic reduction in the expression of L-selectin (CD62L) on monocytes, and to a 4 lesser extent on neutrophils, following mycobacterial stimulation. This observation is in line with 5 previous reports which demonstrated that in response to activation signals, L-selectin is shed 6 from the surface of neutrophils and monocytes within minutes (Janke, et al. 2009; Nijhuis, et al. 7 2007) . Upon the ectodomain shedding of CD62L, its soluble form, sCD62L, is released into the 8 extracellular environment (Ivetic 2013; Smalley and Ley 2005) . Following whole blood 9 stimulation with either mycobacterial preparation, we could not detect any significant increase in 10 sCD62L levels. Nevertheless, the constitutive levels of sCD62L detected in all supernatants 11
were quite high and exceeded 1000 ng/ml. Thus it is quite likely that such high constitutive 12 levels of sCD62L could mask the detection of low levels of sCD62L shedding induced by 13 mycobacterial stimulation (Schleiffenbaum, et al. 1992 ). In addition, our inability to detect 14 sCD62L in unstimulated and mycobacteria-stimulated PBMC culture supernatants, despite the 15 significant downregulation of CD62L expression on monocytes, might be attributed to low 16 amounts of shed CD62L which are below the detection limit of our assay (0.3 ng/mL). better antigen presentation function of mycobacteria-stimulated APC leading to improved T cell 22 activation and survival (Gramaglia, et al. 2000) . In fact, one of the mechanisms by which tumor 23 cells escape immune detection is by down-regulating antigen presentation and costimulatory 24 receptors which would generate anergic T cells incapable of initiating an effective antitumor 25 immune response (Driessens, et al. 2009; Thibodeau, et al. 2012) . Consequently, augmenting 26 the expression of costimulatory receptors might contribute toward enhanced antitumor immunity 27 (Capece, et al. 2012) . 28
We have also shown that mycobacterial stimulation was associated with a significant 29 upregulation of different PRRs, including TLR-2, TLR-4, CD14, CD36 and CD206, on 30 monocytes. This is the first description of an induced expression of CD206 on monocytes in a 31 whole blood model and after a short period of mycobacterial stimulation. Previous studies have 32 demonstrated extremely low or no CD206 expression on resting monocytes, with the CD206 33 expression being restricted to immature DCs and macrophages (Kato, et al. 2000; Noorman, et 1 al. 1997; Wollenberg, et al. 2002) . Therefore, it is likely that mycobacterial stimulation could 2 initiate the expression of markers on monocytes associated with a subsequent potential 3 differentiation of these cells into macrophages. The elevated CD14 and CD282 (TLR-2) gene 4 expression in mycobacteria-stimulated monocytes has been previously reported in M. vaccae-5 stimulated THP-1 human monocytic cell line (Martinelli, et al. 2004) . Such an effect could well 6 contribute towards boosting the recognition of pathogen-associated molecular patterns. On the 7 contrary, some studies have reported a significant downregulation of CD14 expression on 8 purified monocytes that were stimulated with live M. tuberculosis or HK M. avium-M. 9 intracellulare complex for 16 or 48 h, respectively (Santucci, et al. 2000; Tsuyuguchi, et al. 10 1990) . The apparent contradiction in CD14 expression between our study and other studies 11 previously reported might be attributed to differences in the culture systems, in the nature of 12 stimulus, and/or in the stimulation periods utilized. Although both mycobacterial preparations altered the expression of various surface 22 receptors on neutrophils and monocytes, no significant effect could be observed on 23 lymphocytes. The lack of a modulatory effect by both mycobacterial preparations on 24 lymphocytes might be attributed to the short 3 h stimulation period adopted in our whole blood 25 culture system. Using purified PBMCs and longer stimulation periods of 24 and 48 h, a previous 26 study has shown that, in vitro, both HK M. vaccae and M. obuense upregulated the surface 27 expression of various activation receptors on the γδ T lymphocyte subpopulation (Fowler, et al. 28 2012) . Moreover, in vivo treatment with these HK mycobacterial preparations has been reported 29 to induce, few weeks later, a measurable activation of cytotoxic T lymphocytes (Elia, et al. 30 2013) . Another potential explanation is that blood lymphocytes fail to recognize both 31 mycobacterial preparations due to the absence, or barely detectable surface expression of TLR-32 explanation is further substantiated by the inability to detect the surface expression of TLR-2 on 1 lymphocytes in our system (data not shown). 2
Mycobacteria are known to trigger host immune responses following initial interaction 3
with innate immune cells through selected PRRs (Killick, et al. 2013; Kleinnijenhuis, et al. 2011) . 4
A HK preparation of M. vaccae has been previously reported to induce in vitro DC activation via 5 TLR2 (Le Bert, et al. 2011) . To determine whether the interaction between HK M. obuense and 6
TLRs was responsible for the increased surface expression of receptors on monocytes, blocking 7 experiments with antibodies against TLR-1, 2, 4, 5 and 6 were carried out. These experiments 8 clearly indicated that in human whole blood, blocking of TLR-1 and/or TLR-2 significantly 9 inhibited the M. obuense-induced upregulation of CD11c and HLA-DR surface expression on 10 monocytes. Despite the blocking of TLR-1 and/or TLR-2, the expression levels of CD11c and 11 HLA-DR remained higher than those of unstimulated monocytes (p < 0.05) and therefore a 12 possible participation of other receptors, such as nucleotide oligomerisation domain 2 (Nod-2) 13 receptor, in mediating the biological effects of M. obuense cannot be excluded (Behr and 14
Divangahi 2015). Differences in the average MFI values of MHC class II between TLR-blocking 15
experiments (Fig. 2B ) and immunophenotyping experiments (Table 1) can be explained by the 16 fact that in TLR-blocking experiments, we used an antibody specific for only HLA-DR whereas in 17 the immunophenotyping experiments an antibody recognizing the three MHC class II antigens, 18 namely HLA-DPDQDR, was employed. 19
In the current work, we have measured a battery of cytokines and chemokines in 20 supernatants of whole-blood cultures following 24 h of whole blood stimulation with M. vaccae 21 or M. obuense. Among the cytokines tested, IL-6, IL-10, and TNF-α were significantly elevated 22 following mycobacterial stimulation. This is in line with previous reports indicating the release of 23 considerable amounts of IL-6, IL-10, and TNF-α upon activation of monocytes (Damsgaard, et 24 al. 2009 ), the ability of M. vaccae to induce IL-10 and TNF-α production in cultures of isolated 25 monocytes (Baran, et al. 2004) , and increased secretion of IL-10 and TNF-α in PBMC cultures 26 stimulated with HK M. bovis (Moreira, et al. 2012) . Moreover, mycobacterial stimulation 27 enhanced the production of the three tested chemokines: CXCL8/IL-8 and MIP-1α. In contrast, 28 whole blood stimulation with HK mycobacteria did not induce the release of any of the signature 29 T cell cytokines, IFN-γ, IL-2 or IL-4. Thus, the profile of HK mycobacteria-induced cytokines and 30 chemokines in the in vitro system used is most likely monocyte-derived and triggered by 31 structures common to the two organisms. Among such structures are cell wall components 32 containing muramyl peptides as well as heat shock proteins (HSPs) which have been reported 33 to induce a range of proinflammatory cytokines and chemokines either in vitro or in vivo (Asea, 1 et al. 2000; Bahr, et al. 2003; Darcissac, et al. 1996b; Stanford, et al. 2009; Wang, et al. 2002) . 2 This profile of cytokine release, dominated by IL-10 and proinflammatory cytokines, was also 3 reported following whole blood stimulation with HK Lactobacillus rhamnosus, Helicobacter 4 pylori, Burkholderia pseudomallei, MDP, and LPS (Darcissac, et al. 1996b; Duffy, et al. 2014; 5 Myers, et al. 2014 ). On the other hand, the release of cytokines that play a direct role in the 6 adaptive immune system has been reported to occur in whole blood cultures from healthy 7 antigens. Previous studies, conducted to analyze the sensitization to environmental 27 mycobacteria in north Lebanon, southeast England, and northern Malawi by skin testing and/or 28 whole blood IFN- release assay, revealed a very low level of exposure to some environmental 29 mycobacteria including M. vaccae (Bahr, et al. 1986; Black, et al. 2001; Weir, et al. 2003) . 30
Moreover, the healthy donors tested were not previously vaccinated with BCG in line 31 with the policy adopted by the local health authorities. However, several studies have indicated 32 that different mycobacterial species possess cross-reacting T-cell epitopes which could induce 33 the proliferation of sensitized T-cell clones (Oftung, et al. 1998; Sieling, et al. 2005) . Therefore, 1 M. vaccae-and M. obuense-specific T cells are likely to exhibit a broad spectrum of cross-2 reactivity with an as yet to be identified environmental mycobacterial species that could be 3 abundant in the Lebanese environment and could elicit the observed lymphoproliferative 4
responses. 5
As a limitation of the current study, our preliminary kinetics experiments were based on 6 determining the optimal regulation of two surface receptors, and only at two time points, in 7 response to mycobacterial stimulation. However, other receptors analyzed in this study might 8 display optimal regulation at different stimulation periods. An additional limitation of our study 9 was the analysis of cytokine levels at a single time point following mycobacterial stimulation of 10 whole blood. Previous studies have emphasized the importance of identifying optimal 11 stimulation time points correlating with peak levels of cytokines since these time points are 12 cytokine-and stimulus-dependent (Hermann, et al. 2003; Lagrelius, et al. 2006) . For instance, 13
we could not detect IFN-γ levels in 24 h mycobacteria-stimulated whole blood cultures. 14 However, other studies employing longer stimulation periods of 5 and 6 days were capable of 15 detecting IFN-γ in whole blood cultures stimulated with specific M. tuberculosis antigens (Antas, 16 et al. 2004; Deenadayalan, et al. 2013; Silva, et al. 2013 ). Thus, future kinetic studies employing 17 additional and extended time points might be useful in addressing the effect of mycobacterial 18 stimulation on the expression of other surface receptors and on the release of cytokines. 19
In conclusion, our study revealed a potent ability of HK cell preparations of M. vaccae 20 and M. obuense to regulate the expression of several receptors on phagocytic cells, and to 21 induce the release of a specific set of cytokines and chemokines in this whole blood in vitro 22 system. The data provided could serve as a baseline to explain the outcome of interaction 23 between HK mycobacterial preparations and immune cells which in additional future studies 24 might be correlated with the previously known in vivo activities of HK mycobacterial preparations 25 such as the adjuvant, the anti-infectious, and the anti-tumor effects 26
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